The project is designed to progress over 48 months, segmented into distinct phases to facilitate systematic implementation and evaluation.

The initial phase (Months 1–12) focuses on laying the scientific and technological foundations, including the development of research methodologies, co-design protocols, and the establishment of the VIPPSTAR-NET infrastructure.

The second phase (Months 13–24) transitions to the design, prototyping, and preliminary testing of digital tools, allowing for iterative feedback from users and stakeholders.

The third phase (Months 25–36) emphasizes clinical validation through randomized controlled trials (RCTs), evaluating the tools’ impact on visual function, cognitive development, and quality of life.

The final phase (Months 37–48) concentrates on finalizing regulatory frameworks, disseminating validated findings, and preparing a sustainability strategy through the adoption roadmap. This phased approach ensures the achievement of project milestones, fostering incremental innovation while maintaining rigorous scientific standards.

Elisa Fazzi - Project Coordinator

M1 - M18

This WP focuses on establishing the project’s organizational structure and management processes. It oversees partner communication, defines project workflows, manages financial resources, and ensures compliance with deliverables and milestones in the early phase.

Elisa Fazzi - Project Coordinator

M19 - M36

This WP continues administrative and scientific coordination, focusing on reviewing progress, mitigating risks, and ensuring that all ongoing activities align with the project objectives. It guarantees smooth execution of the mid-phase activities.

Elisa Fazzi - Project Coordinator

M37 - M48

WP3 ensures the final phase of project coordination, including preparation for reporting, consolidation of results, and completion of final deliverables. It facilitates the transition to dissemination and ensures compliance with legal, financial, and ethical standards.

-

M1 - M18

This WP focuses on the initial development of AI-based solutions, adhering to ethical guidelines and technical standards. It aims to create adaptive tools that integrate into the rehabilitation process while ensuring transparency, safety, and reliability.

-

M19 - M48

Building on WP4, this WP enhances the AI systems with advanced functionalities to improve usability and effectiveness. It integrates iterative feedback from trials, aligning the solutions with the regulatory and clinical requirements of the project.

-

M1 - M18

WP6 develops the foundational methodologies and frameworks for digital health tools. It ensures that the scientific and technical aspects of the project meet the demands of clinical applications, focusing on precision, scalability, and interoperability.

-

M6 - M48

WP7 establishes a clinical data surveillance network to monitor epidemiological trends in visual impairments. It supports harmonized data collection across multiple countries, enabling the assessment of VIPPSTAR interventions' long-term impact and scalability.

-

M4 - M18

This WP focuses on the design and development of digital tools tailored for individuals with VI. The tools include serious games and assistive technologies aimed at improving motor, cognitive, and social skills, aligning with the therapeutic goals of the project.

-

M19 - M36

WP9 advances the digital tools created in WP8, incorporating enhanced features and new functionalities to better address the diverse needs of users with VI. This includes extending the scope of tools to additional rehabilitation areas based on clinical feedback.

-

M7 - M36

This WP delivers the first version of the VIPPSTAR platform, providing an integrated environment for delivering personalized interventions. It includes basic functionalities for remote support and monitoring, ensuring ease of use for both clinicians and patients.

-

M1 - M36

Building on WP10, this WP enhances the VIPPSTAR platform with additional tools and improved interfaces, ensuring that it can deliver robust and comprehensive support for rehabilitation. It includes usability testing and optimization to maximize accessibility.

-

M18 - M48

This WP manages the execution of randomized controlled trials (RCTs) to evaluate the efficacy and safety of the project tools. It oversees participant recruitment, data collection, and analysis, ensuring that all clinical trials meet ethical and regulatory standards.

-

M24 - M48

WP13 creates a detailed adoption roadmap for the VIPPSTAR technologies, focusing on market integration, stakeholder engagement, and regulatory compliance. It ensures the solutions are sustainable and viable beyond the project’s completion.

-

M1 - M48

This WP ensures effective communication with stakeholders during the initial phase. It promotes project goals through publications, events, and collaboration with community organizations, focusing on creating awareness and fostering engagement.

-

M1 - M36

WP15 continues dissemination and exploitation activities, expanding engagement with policymakers, healthcare providers, and the public. It focuses on highlighting the project’s progress and ensuring wide-scale visibility of intermediate results and outcomes.

-

M36 - M48

This WP consolidates all dissemination efforts, ensuring that the project outcomes are integrated into clinical practices and policies. It also prepares the final communication reports and develops strategies for sustaining the project’s impact post-completion.